

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma membrane repair (GO:0001778) | 5.49541171 |
| 2 | sarcomere organization (GO:0045214) | 5.25756375 |
| 3 | muscle filament sliding (GO:0030049) | 5.06965846 |
| 4 | actin-myosin filament sliding (GO:0033275) | 5.06965846 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.84408652 |
| 6 | negative regulation of cell size (GO:0045792) | 4.81685125 |
| 7 | protein maturation by protein folding (GO:0022417) | 4.69627055 |
| 8 | carnitine shuttle (GO:0006853) | 4.55730006 |
| 9 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.51310151 |
| 10 | COPI coating of Golgi vesicle (GO:0048205) | 4.39984879 |
| 11 | Golgi transport vesicle coating (GO:0048200) | 4.39984879 |
| 12 | cardiac myofibril assembly (GO:0055003) | 4.34671354 |
| 13 | regulation of skeletal muscle contraction (GO:0014819) | 4.28491376 |
| 14 | tricarboxylic acid cycle (GO:0006099) | 4.17767347 |
| 15 | myofibril assembly (GO:0030239) | 4.10030111 |
| 16 | barbed-end actin filament capping (GO:0051016) | 4.07509568 |
| 17 | fatty acid transmembrane transport (GO:1902001) | 4.02685327 |
| 18 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.92789533 |
| 19 | carnitine transmembrane transport (GO:1902603) | 3.91441070 |
| 20 | cardiac muscle contraction (GO:0060048) | 3.86203224 |
| 21 | actin-mediated cell contraction (GO:0070252) | 3.85354164 |
| 22 | positive regulation of histone deacetylation (GO:0031065) | 3.83686929 |
| 23 | maternal placenta development (GO:0001893) | 3.81451378 |
| 24 | amino-acid betaine transport (GO:0015838) | 3.76296276 |
| 25 | carnitine transport (GO:0015879) | 3.76296276 |
| 26 | negative regulation of heart growth (GO:0061117) | 3.67957453 |
| 27 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.67957453 |
| 28 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.67575409 |
| 29 | skin morphogenesis (GO:0043589) | 3.66152470 |
| 30 | protein retention in ER lumen (GO:0006621) | 3.64437287 |
| 31 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.59220497 |
| 32 | UV protection (GO:0009650) | 3.58142673 |
| 33 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.54468045 |
| 34 | actomyosin structure organization (GO:0031032) | 3.50097062 |
| 35 | nuclear envelope reassembly (GO:0031468) | 3.45316678 |
| 36 | mitotic nuclear envelope reassembly (GO:0007084) | 3.45316678 |
| 37 | regulation of fatty acid oxidation (GO:0046320) | 3.44212619 |
| 38 | 2-oxoglutarate metabolic process (GO:0006103) | 3.43999342 |
| 39 | striated muscle contraction (GO:0006941) | 3.42568771 |
| 40 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.37598503 |
| 41 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.37470397 |
| 42 | skeletal muscle adaptation (GO:0043501) | 3.35574641 |
| 43 | cardiac muscle cell development (GO:0055013) | 3.34920720 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 3.33429994 |
| 45 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.33225659 |
| 46 | pinocytosis (GO:0006907) | 3.31839706 |
| 47 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.30183746 |
| 48 | peptidyl-lysine dimethylation (GO:0018027) | 3.30038932 |
| 49 | positive regulation of myotube differentiation (GO:0010831) | 3.26643942 |
| 50 | stress fiber assembly (GO:0043149) | 3.25531662 |
| 51 | actin filament-based movement (GO:0030048) | 3.23384607 |
| 52 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 3.22658486 |
| 53 | focal adhesion assembly (GO:0048041) | 3.20929045 |
| 54 | cell-substrate adherens junction assembly (GO:0007045) | 3.20929045 |
| 55 | adherens junction assembly (GO:0034333) | 3.19236638 |
| 56 | skeletal muscle contraction (GO:0003009) | 3.18842418 |
| 57 | 4-hydroxyproline metabolic process (GO:0019471) | 3.17819998 |
| 58 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.14762259 |
| 59 | cardiac cell development (GO:0055006) | 3.14713262 |
| 60 | tricarboxylic acid metabolic process (GO:0072350) | 3.14066542 |
| 61 | lysine metabolic process (GO:0006553) | 3.13782598 |
| 62 | lysine catabolic process (GO:0006554) | 3.13782598 |
| 63 | protein localization to endosome (GO:0036010) | 3.10414468 |
| 64 | cell-substrate junction assembly (GO:0007044) | 3.08561311 |
| 65 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.08175363 |
| 66 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.08095303 |
| 67 | oxaloacetate metabolic process (GO:0006107) | 3.07301842 |
| 68 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.05908547 |
| 69 | heart trabecula formation (GO:0060347) | 3.05544875 |
| 70 | protein hydroxylation (GO:0018126) | 3.03862326 |
| 71 | creatine metabolic process (GO:0006600) | 3.01145312 |
| 72 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.99809781 |
| 73 | regulation of defense response to virus by virus (GO:0050690) | 2.98610812 |
| 74 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.97508031 |
| 75 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.97007939 |
| 76 | regulation of p38MAPK cascade (GO:1900744) | 2.96061348 |
| 77 | type B pancreatic cell proliferation (GO:0044342) | 2.95148258 |
| 78 | membrane raft organization (GO:0031579) | 2.91880464 |
| 79 | positive regulation of protein deacetylation (GO:0090312) | 2.91532841 |
| 80 | mitochondrial fusion (GO:0008053) | 2.90897886 |
| 81 | apoptotic cell clearance (GO:0043277) | 2.90525989 |
| 82 | negative regulation of fatty acid transport (GO:2000192) | 2.88527980 |
| 83 | modulation by symbiont of host cellular process (GO:0044068) | 2.88391160 |
| 84 | hemidesmosome assembly (GO:0031581) | 2.88104974 |
| 85 | ribosomal small subunit biogenesis (GO:0042274) | 2.87672417 |
| 86 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.87620461 |
| 87 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.87620461 |
| 88 | GDP-mannose metabolic process (GO:0019673) | 2.86514646 |
| 89 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.84998611 |
| 90 | glycogen catabolic process (GO:0005980) | 2.82872760 |
| 91 | peptidyl-proline hydroxylation (GO:0019511) | 2.82848237 |
| 92 | aspartate family amino acid catabolic process (GO:0009068) | 2.82564330 |
| 93 | modulation by virus of host process (GO:0019054) | 2.78102987 |
| 94 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.77257017 |
| 95 | quaternary ammonium group transport (GO:0015697) | 2.76720617 |
| 96 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.75325366 |
| 97 | cell communication by electrical coupling (GO:0010644) | 2.75195671 |
| 98 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.75113387 |
| 99 | regulation of early endosome to late endosome transport (GO:2000641) | 2.74796350 |
| 100 | NADH metabolic process (GO:0006734) | 2.74506877 |
| 101 | pentose-phosphate shunt (GO:0006098) | 2.74318269 |
| 102 | hypotonic response (GO:0006971) | 2.73150868 |
| 103 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.69033222 |
| 104 | endothelial cell chemotaxis (GO:0035767) | 2.68030740 |
| 105 | epithelial cell-cell adhesion (GO:0090136) | 2.67850749 |
| 106 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.67676374 |
| 107 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.67091503 |
| 108 | valine metabolic process (GO:0006573) | 2.66866755 |
| 109 | glycolytic process (GO:0006096) | 2.63965181 |
| 110 | positive regulation of fatty acid oxidation (GO:0046321) | 2.63814056 |
| 111 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.62701379 |
| 112 | apoptotic process involved in morphogenesis (GO:0060561) | 2.62413896 |
| 113 | establishment of viral latency (GO:0019043) | 2.62268248 |
| 114 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.62069325 |
| 115 | sodium ion export (GO:0071436) | 2.61699418 |
| 116 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.61341053 |
| 117 | muscle contraction (GO:0006936) | 2.61078288 |
| 118 | glycogen metabolic process (GO:0005977) | 2.60202767 |
| 119 | regulation of translational termination (GO:0006449) | 2.59801755 |
| 120 | glucan catabolic process (GO:0009251) | 2.59002968 |
| 121 | cell adhesion mediated by integrin (GO:0033627) | 2.58410124 |
| 122 | pyrimidine nucleoside salvage (GO:0043097) | 2.58332580 |
| 123 | pyrimidine-containing compound salvage (GO:0008655) | 2.58332580 |
| 124 | positive regulation of nuclease activity (GO:0032075) | 2.55873887 |
| 125 | virion assembly (GO:0019068) | 2.54934869 |
| 126 | regulation of tight junction assembly (GO:2000810) | 2.54128682 |
| 127 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.54081231 |
| 128 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.53631213 |
| 129 | cellular glucan metabolic process (GO:0006073) | 2.53361401 |
| 130 | glucan metabolic process (GO:0044042) | 2.53361401 |
| 131 | regulation of hippo signaling (GO:0035330) | 2.50921680 |
| 132 | striated muscle atrophy (GO:0014891) | 2.50480305 |
| 133 | fatty acid beta-oxidation (GO:0006635) | 2.50317976 |
| 134 | regulation of translational fidelity (GO:0006450) | 2.50186502 |
| 135 | platelet aggregation (GO:0070527) | 2.50050220 |
| 136 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.49774681 |
| 137 | hyaluronan catabolic process (GO:0030214) | 2.49579294 |
| 138 | virion attachment to host cell (GO:0019062) | 2.48774487 |
| 139 | adhesion of symbiont to host cell (GO:0044650) | 2.48774487 |
| 140 | activation of Rac GTPase activity (GO:0032863) | 2.48664860 |
| 141 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.47854929 |
| 142 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.47800539 |
| 143 | cellular response to osmotic stress (GO:0071470) | 2.47376958 |
| 144 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.46958330 |
| 145 | gluconeogenesis (GO:0006094) | 2.46662528 |
| 146 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.46570746 |
| 147 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.46397378 |
| 148 | regulation of superoxide anion generation (GO:0032928) | 2.45856854 |
| 149 | positive regulation of lamellipodium assembly (GO:0010592) | 2.45485267 |
| 150 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.44868099 |
| 151 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.44218736 |
| 152 | glucose catabolic process (GO:0006007) | 2.43349828 |
| 153 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.43246941 |
| 154 | low-density lipoprotein particle clearance (GO:0034383) | 2.42827251 |
| 155 | actin filament depolymerization (GO:0030042) | 2.42566671 |
| 156 | viral protein processing (GO:0019082) | 2.42359833 |
| 157 | negative regulation of necroptotic process (GO:0060546) | 2.41909102 |
| 158 | mature B cell differentiation involved in immune response (GO:0002313) | 2.38828464 |
| 159 | glial cell migration (GO:0008347) | 2.38240202 |
| 160 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.37359220 |
| 161 | protein heterotrimerization (GO:0070208) | 2.37278852 |
| 162 | negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059) | 2.36328430 |
| 163 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.35931320 |
| 164 | cellular response to virus (GO:0098586) | 2.35930477 |
| 165 | negative regulation of ERBB signaling pathway (GO:1901185) | 2.35798513 |
| 166 | regulation of monocyte chemotaxis (GO:0090025) | 2.35145476 |
| 167 | regulation of necrotic cell death (GO:0010939) | 2.33820979 |
| 168 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.32550798 |
| 169 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.32405701 |
| 170 | response to peptidoglycan (GO:0032494) | 2.32111981 |
| 171 | regulation of metalloenzyme activity (GO:0048552) | 2.31928806 |
| 172 | response to progesterone (GO:0032570) | 2.31064106 |
| 173 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.30678592 |
| 174 | positive regulation of macrophage differentiation (GO:0045651) | 2.30206041 |
| 175 | endodermal cell differentiation (GO:0035987) | 2.30078333 |
| 176 | decidualization (GO:0046697) | 2.29913941 |
| 177 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.29529902 |
| 178 | adhesion of symbiont to host (GO:0044406) | 2.27431660 |
| 179 | fibril organization (GO:0097435) | 2.27211049 |
| 180 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.25789669 |
| 181 | cortical actin cytoskeleton organization (GO:0030866) | 2.25685492 |
| 182 | response to gravity (GO:0009629) | 2.25400720 |
| 183 | actin nucleation (GO:0045010) | 2.24645055 |
| 184 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.24422342 |
| 185 | type I interferon signaling pathway (GO:0060337) | 2.23116362 |
| 186 | cellular response to type I interferon (GO:0071357) | 2.23116362 |
| 187 | activation of MAPKKK activity (GO:0000185) | 2.22473355 |
| 188 | extracellular fibril organization (GO:0043206) | 2.19651784 |
| 189 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.19406078 |
| 190 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.18443194 |
| 191 | response to type I interferon (GO:0034340) | 2.18365201 |
| 192 | protein targeting to plasma membrane (GO:0072661) | 2.16953393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.05170695 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.78511217 |
| 3 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.68745834 |
| 4 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.56553523 |
| 5 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.50287050 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.49898894 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.45609340 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.44248179 |
| 9 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.34703003 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.32491482 |
| 11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.30884935 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.19492487 |
| 13 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.15794131 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.12998906 |
| 15 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.06500269 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.03887445 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02920188 |
| 18 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.98906841 |
| 19 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.98230384 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.91228247 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87912978 |
| 22 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.86355701 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.78597404 |
| 24 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.75740780 |
| 25 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.72547967 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.71803479 |
| 27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.70510366 |
| 28 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.70247714 |
| 29 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.70247714 |
| 30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.69023486 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.67672574 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66228687 |
| 33 | P68_20966046_ChIP-Seq_HELA_Human | 1.66071775 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.65761760 |
| 35 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.63909882 |
| 36 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.61350377 |
| 37 | ATF3_27146783_Chip-Seq_COLON_Human | 1.60574871 |
| 38 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60215212 |
| 39 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.57516465 |
| 40 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.57134496 |
| 41 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.55232368 |
| 42 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54337142 |
| 43 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.53159507 |
| 44 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.51831216 |
| 45 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.51681344 |
| 46 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.50782490 |
| 47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50474305 |
| 48 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.46670872 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.46047635 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44396215 |
| 51 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.43756989 |
| 52 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.43750978 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.43303999 |
| 54 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.43266364 |
| 55 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.43165389 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42795563 |
| 57 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42365924 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42181079 |
| 59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.41614951 |
| 60 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.41453584 |
| 61 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.40972775 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40501202 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.39841779 |
| 64 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.38710056 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38132730 |
| 66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.37990801 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36944034 |
| 68 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35877415 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.35720433 |
| 70 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35594056 |
| 71 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34669060 |
| 72 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.33715320 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33100369 |
| 74 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.32863381 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29600601 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28946056 |
| 77 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.28365201 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27946711 |
| 79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27875699 |
| 80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27754776 |
| 81 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.27477677 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27100710 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26284394 |
| 84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25684524 |
| 85 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.25404236 |
| 86 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.24555412 |
| 87 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.24444488 |
| 88 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.24220231 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.24182991 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23731633 |
| 91 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.23563805 |
| 92 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23422088 |
| 93 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.23091082 |
| 94 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.22989268 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.21550896 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.21456463 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20680075 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19439087 |
| 99 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19419516 |
| 100 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.18809656 |
| 101 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.18068187 |
| 102 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17619027 |
| 103 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.14564085 |
| 104 | MAF_26560356_Chip-Seq_TH2_Human | 1.14467455 |
| 105 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.14093604 |
| 106 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.13990669 |
| 107 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13634132 |
| 108 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.11376305 |
| 109 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.10830653 |
| 110 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.10659365 |
| 111 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.10626154 |
| 112 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10417251 |
| 113 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.09991187 |
| 114 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09610716 |
| 115 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08971430 |
| 116 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08562837 |
| 117 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07901791 |
| 118 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.07017880 |
| 119 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06868371 |
| 120 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06672101 |
| 121 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.06498263 |
| 122 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06227922 |
| 123 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05799365 |
| 124 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05559282 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04403096 |
| 126 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.03988671 |
| 127 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.03322203 |
| 128 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03196889 |
| 129 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03044851 |
| 130 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.02293154 |
| 131 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01689057 |
| 132 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01444755 |
| 133 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01353596 |
| 134 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01326129 |
| 135 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01019600 |
| 136 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00650615 |
| 137 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00162162 |
| 138 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.99978607 |
| 139 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99972091 |
| 140 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.99907963 |
| 141 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99855857 |
| 142 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97595139 |
| 143 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97360046 |
| 144 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.97233057 |
| 145 | SPI1_23127762_ChIP-Seq_K562_Human | 0.96163711 |
| 146 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95533166 |
| 147 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95063880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.66538688 |
| 2 | MP0000751_myopathy | 4.41501939 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 4.10326125 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.73739084 |
| 5 | MP0000749_muscle_degeneration | 3.42339359 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.03159610 |
| 7 | MP0004036_abnormal_muscle_relaxation | 2.90307623 |
| 8 | MP0004087_abnormal_muscle_fiber | 2.89413123 |
| 9 | MP0005451_abnormal_body_composition | 2.80272058 |
| 10 | MP0004130_abnormal_muscle_cell | 2.80091566 |
| 11 | MP0000750_abnormal_muscle_regeneration | 2.75790712 |
| 12 | MP0004145_abnormal_muscle_electrophysio | 2.64794095 |
| 13 | MP0002269_muscular_atrophy | 2.59896439 |
| 14 | MP0005330_cardiomyopathy | 2.58747007 |
| 15 | MP0003436_decreased_susceptibility_to | 2.54669888 |
| 16 | MP0002106_abnormal_muscle_physiology | 2.38875846 |
| 17 | MP0000759_abnormal_skeletal_muscle | 2.33271059 |
| 18 | MP0000858_altered_metastatic_potential | 2.29501370 |
| 19 | MP0000747_muscle_weakness | 2.29402482 |
| 20 | MP0008438_abnormal_cutaneous_collagen | 2.27538015 |
| 21 | MP0001542_abnormal_bone_strength | 2.11993204 |
| 22 | MP0004233_abnormal_muscle_weight | 2.10964665 |
| 23 | MP0008260_abnormal_autophagy | 2.00426752 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 2.00207788 |
| 25 | MP0006082_CNS_inflammation | 1.95932059 |
| 26 | MP0005369_muscle_phenotype | 1.92620823 |
| 27 | MP0010630_abnormal_cardiac_muscle | 1.89792019 |
| 28 | MP0005666_abnormal_adipose_tissue | 1.86928746 |
| 29 | MP0005620_abnormal_muscle_contractility | 1.86127821 |
| 30 | MP0008961_abnormal_basal_metabolism | 1.80728039 |
| 31 | MP0004947_skin_inflammation | 1.79674324 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.77031840 |
| 33 | MP0004215_abnormal_myocardial_fiber | 1.76934443 |
| 34 | MP0004510_myositis | 1.76802855 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.76496348 |
| 36 | MP0000733_abnormal_muscle_development | 1.75954177 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.74718318 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.73830036 |
| 39 | MP0005623_abnormal_meninges_morphology | 1.64295071 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.60453699 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.58919483 |
| 42 | MP0002972_abnormal_cardiac_muscle | 1.57504270 |
| 43 | MP0003279_aneurysm | 1.56779478 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.56254289 |
| 45 | MP0002877_abnormal_melanocyte_morpholog | 1.55515257 |
| 46 | MP0005385_cardiovascular_system_phenoty | 1.55305470 |
| 47 | MP0001544_abnormal_cardiovascular_syste | 1.55305470 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.50529631 |
| 49 | MP0002060_abnormal_skin_morphology | 1.49491046 |
| 50 | MP0009785_altered_susceptibility_to | 1.48174825 |
| 51 | MP0009278_abnormal_bone_marrow | 1.47581097 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.47527914 |
| 53 | MP0005025_abnormal_response_to | 1.45854077 |
| 54 | MP0005275_abnormal_skin_tensile | 1.43062636 |
| 55 | MP0003448_altered_tumor_morphology | 1.43008955 |
| 56 | MP0009840_abnormal_foam_cell | 1.42898369 |
| 57 | MP0002419_abnormal_innate_immunity | 1.39131953 |
| 58 | MP0008775_abnormal_heart_ventricle | 1.38405307 |
| 59 | MP0000685_abnormal_immune_system | 1.37069034 |
| 60 | MP0001835_abnormal_antigen_presentation | 1.36981372 |
| 61 | MP0003283_abnormal_digestive_organ | 1.36557701 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.35960633 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.35809973 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.35786340 |
| 65 | MP0005501_abnormal_skin_physiology | 1.35142588 |
| 66 | MP0001958_emphysema | 1.35081644 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 1.34352225 |
| 68 | MP0005670_abnormal_white_adipose | 1.32770807 |
| 69 | MP0003137_abnormal_impulse_conducting | 1.32397490 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 1.31933561 |
| 71 | MP0002909_abnormal_adrenal_gland | 1.31379438 |
| 72 | MP0001243_abnormal_dermal_layer | 1.28416606 |
| 73 | MP0000604_amyloidosis | 1.27513242 |
| 74 | MP0003300_gastrointestinal_ulcer | 1.26689877 |
| 75 | MP0002234_abnormal_pharynx_morphology | 1.25752131 |
| 76 | MP0001853_heart_inflammation | 1.24832872 |
| 77 | MP0003763_abnormal_thymus_physiology | 1.24446846 |
| 78 | MP0004858_abnormal_nervous_system | 1.24324958 |
| 79 | MP0002998_abnormal_bone_remodeling | 1.24158346 |
| 80 | MP0005390_skeleton_phenotype | 1.22373002 |
| 81 | MP0001849_ear_inflammation | 1.18171815 |
| 82 | MP0000013_abnormal_adipose_tissue | 1.18080642 |
| 83 | MP0006138_congestive_heart_failure | 1.16778987 |
| 84 | MP0002723_abnormal_immune_serum | 1.13839430 |
| 85 | MP0002796_impaired_skin_barrier | 1.12395932 |
| 86 | MP0004484_altered_response_of | 1.10986214 |
| 87 | MP0002420_abnormal_adaptive_immunity | 1.10973832 |
| 88 | MP0001819_abnormal_immune_cell | 1.09977786 |
| 89 | MP0002452_abnormal_antigen_presenting | 1.09943039 |
| 90 | MP0005076_abnormal_cell_differentiation | 1.08698433 |
| 91 | MP0000003_abnormal_adipose_tissue | 1.08176920 |
| 92 | MP0000343_altered_response_to | 1.07989224 |
| 93 | MP0002108_abnormal_muscle_morphology | 1.06455085 |
| 94 | MP0002332_abnormal_exercise_endurance | 1.04721293 |
| 95 | MP0003172_abnormal_lysosome_physiology | 1.02930146 |
| 96 | MP0003303_peritoneal_inflammation | 1.01847198 |
| 97 | MP0005410_abnormal_fertilization | 1.01841620 |
| 98 | MP0009053_abnormal_anal_canal | 1.00896096 |
| 99 | MP0005671_abnormal_response_to | 1.00028280 |
| 100 | MP0000678_abnormal_parathyroid_gland | 0.99887997 |
| 101 | MP0000266_abnormal_heart_morphology | 0.98327846 |
| 102 | MP0009384_cardiac_valve_regurgitation | 0.96726235 |
| 103 | MP0002089_abnormal_postnatal_growth/wei | 0.95328550 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.92633015 |
| 105 | MP0005164_abnormal_response_to | 0.92095249 |
| 106 | MP0001790_abnormal_immune_system | 0.90893945 |
| 107 | MP0005387_immune_system_phenotype | 0.90893945 |
| 108 | MP0002398_abnormal_bone_marrow | 0.90515790 |
| 109 | MP0005023_abnormal_wound_healing | 0.90497573 |
| 110 | MP0002971_abnormal_brown_adipose | 0.90141557 |
| 111 | MP0005166_decreased_susceptibility_to | 0.89621014 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.89405314 |
| 113 | MP0005508_abnormal_skeleton_morphology | 0.87370331 |
| 114 | MP0000490_abnormal_crypts_of | 0.86730855 |
| 115 | MP0002933_joint_inflammation | 0.86185850 |
| 116 | MP0002429_abnormal_blood_cell | 0.85772070 |
| 117 | MP0001873_stomach_inflammation | 0.85537842 |
| 118 | MP0001845_abnormal_inflammatory_respons | 0.85424493 |
| 119 | MP0002405_respiratory_system_inflammati | 0.85364043 |
| 120 | MP0000716_abnormal_immune_system | 0.85216872 |
| 121 | MP0003828_pulmonary_edema | 0.84819302 |
| 122 | MP0004085_abnormal_heartbeat | 0.84422533 |
| 123 | MP0008469_abnormal_protein_level | 0.84128882 |
| 124 | MP0003191_abnormal_cellular_cholesterol | 0.84060598 |
| 125 | MP0003795_abnormal_bone_structure | 0.83395270 |
| 126 | MP0005083_abnormal_biliary_tract | 0.82029990 |
| 127 | MP0003045_fibrosis | 0.81757039 |
| 128 | MP0004808_abnormal_hematopoietic_stem | 0.80884747 |
| 129 | MP0005621_abnormal_cell_physiology | 0.80524386 |
| 130 | MP0002722_abnormal_immune_system | 0.80051440 |
| 131 | MP0001800_abnormal_humoral_immune | 0.79572526 |
| 132 | MP0010368_abnormal_lymphatic_system | 0.79413218 |
| 133 | MP0003075_altered_response_to | 0.79235902 |
| 134 | MP0002653_abnormal_ependyma_morphology | 0.78633245 |
| 135 | MP0000681_abnormal_thyroid_gland | 0.78048620 |
| 136 | MP0000358_abnormal_cell_content/ | 0.77755071 |
| 137 | MP0002128_abnormal_blood_circulation | 0.77059972 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.76688010 |
| 139 | MP0005319_abnormal_enzyme/_coenzyme | 0.76256673 |
| 140 | MP0004272_abnormal_basement_membrane | 0.75367249 |
| 141 | MP0003091_abnormal_cell_migration | 0.67436233 |
| 142 | MP0009115_abnormal_fat_cell | 0.66611075 |
| 143 | MP0009780_abnormal_chondrocyte_physiolo | 0.65661168 |
| 144 | MP0002970_abnormal_white_adipose | 0.64897132 |
| 145 | MP0000767_abnormal_smooth_muscle | 0.64081187 |
| 146 | MP0005165_increased_susceptibility_to | 0.61494094 |
| 147 | MP0004859_abnormal_synaptic_plasticity | 0.60623906 |
| 148 | MP0002925_abnormal_cardiovascular_devel | 0.59199151 |
| 149 | MP0005503_abnormal_tendon_morphology | 0.58845162 |
| 150 | MP0002896_abnormal_bone_mineralization | 0.58282028 |
| 151 | MP0003329_amyloid_beta_deposits | 0.57412691 |
| 152 | MP0008770_decreased_survivor_rate | 0.57083552 |
| 153 | MP0002078_abnormal_glucose_homeostasis | 0.56153025 |
| 154 | MP0000534_abnormal_ureter_morphology | 0.55859275 |
| 155 | MP0001348_abnormal_lacrimal_gland | 0.54612699 |
| 156 | MP0005334_abnormal_fat_pad | 0.53146394 |
| 157 | MP0010234_abnormal_vibrissa_follicle | 0.53028843 |
| 158 | MP0005397_hematopoietic_system_phenotyp | 0.52843523 |
| 159 | MP0001545_abnormal_hematopoietic_system | 0.52843523 |
| 160 | MP0004197_abnormal_fetal_growth/weight/ | 0.52757496 |
| 161 | MP0002127_abnormal_cardiovascular_syste | 0.52584149 |
| 162 | MP0001614_abnormal_blood_vessel | 0.52544295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.42543975 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 5.39077093 |
| 3 | Myoglobinuria (HP:0002913) | 4.50668378 |
| 4 | Sudden death (HP:0001699) | 4.43053158 |
| 5 | Vertebral compression fractures (HP:0002953) | 4.29846045 |
| 6 | Increased connective tissue (HP:0009025) | 4.15877313 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 4.14684426 |
| 8 | Muscle fiber splitting (HP:0003555) | 4.11301581 |
| 9 | Difficulty running (HP:0009046) | 4.04983347 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 4.00737132 |
| 11 | Difficulty climbing stairs (HP:0003551) | 3.97509974 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 3.94942598 |
| 13 | Asymmetric septal hypertrophy (HP:0001670) | 3.89566149 |
| 14 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.83767725 |
| 15 | Ventricular tachycardia (HP:0004756) | 3.61666148 |
| 16 | Muscle fiber inclusion bodies (HP:0100299) | 3.50296813 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.42312496 |
| 18 | Abnormality of the calf musculature (HP:0001430) | 3.37554316 |
| 19 | Increased variability in muscle fiber diameter (HP:0003557) | 3.30972662 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 3.26620288 |
| 21 | Protrusio acetabuli (HP:0003179) | 3.25265739 |
| 22 | Bundle branch block (HP:0011710) | 3.22602771 |
| 23 | Subaortic stenosis (HP:0001682) | 3.22267715 |
| 24 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.22267715 |
| 25 | Myotonia (HP:0002486) | 3.22240437 |
| 26 | Rhabdomyolysis (HP:0003201) | 3.20220764 |
| 27 | Distal lower limb muscle weakness (HP:0009053) | 3.18768883 |
| 28 | Ulnar deviation of the wrist (HP:0003049) | 3.18257505 |
| 29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.15865978 |
| 30 | Round ear (HP:0100830) | 3.13922581 |
| 31 | Cerebral aneurysm (HP:0004944) | 3.02270552 |
| 32 | Achilles tendon contracture (HP:0001771) | 3.00650692 |
| 33 | Muscle stiffness (HP:0003552) | 2.97283365 |
| 34 | Fragile skin (HP:0001030) | 2.87266410 |
| 35 | Short nail (HP:0001799) | 2.82992610 |
| 36 | Abnormality of the Achilles tendon (HP:0005109) | 2.82780038 |
| 37 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.78129469 |
| 38 | Right ventricular cardiomyopathy (HP:0011663) | 2.76913170 |
| 39 | Distal arthrogryposis (HP:0005684) | 2.76199026 |
| 40 | Limb-girdle muscle atrophy (HP:0003797) | 2.72984282 |
| 41 | Atrophic scars (HP:0001075) | 2.69600906 |
| 42 | Nemaline bodies (HP:0003798) | 2.68337537 |
| 43 | Myopathic facies (HP:0002058) | 2.67897348 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.67847103 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.67847103 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.67847103 |
| 47 | Lipoatrophy (HP:0100578) | 2.62243900 |
| 48 | Elbow flexion contracture (HP:0002987) | 2.60136747 |
| 49 | Cervical subluxation (HP:0003308) | 2.52934383 |
| 50 | Frequent falls (HP:0002359) | 2.49445885 |
| 51 | Entropion (HP:0000621) | 2.49257612 |
| 52 | Broad metatarsal (HP:0001783) | 2.47685925 |
| 53 | Upper limb amyotrophy (HP:0009129) | 2.47249651 |
| 54 | Distal upper limb amyotrophy (HP:0007149) | 2.47249651 |
| 55 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.45568419 |
| 56 | Abnormal atrioventricular conduction (HP:0005150) | 2.44203198 |
| 57 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.43102055 |
| 58 | Heart block (HP:0012722) | 2.41374874 |
| 59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.41127488 |
| 60 | Osteolytic defects of the hand bones (HP:0009699) | 2.41127488 |
| 61 | EMG: neuropathic changes (HP:0003445) | 2.38694794 |
| 62 | Rough bone trabeculation (HP:0100670) | 2.37838468 |
| 63 | Axonal loss (HP:0003447) | 2.35531094 |
| 64 | Atrioventricular block (HP:0001678) | 2.33649753 |
| 65 | Atrial fibrillation (HP:0005110) | 2.33251469 |
| 66 | Wormian bones (HP:0002645) | 2.31458848 |
| 67 | Follicular hyperkeratosis (HP:0007502) | 2.30283031 |
| 68 | Primary atrial arrhythmia (HP:0001692) | 2.30039675 |
| 69 | Supraventricular arrhythmia (HP:0005115) | 2.28133618 |
| 70 | Supraventricular tachycardia (HP:0004755) | 2.25585221 |
| 71 | Trismus (HP:0000211) | 2.25206133 |
| 72 | Calcaneovalgus deformity (HP:0001848) | 2.23214542 |
| 73 | Abnormality of the nasal mucosa (HP:0000433) | 2.23122463 |
| 74 | Joint stiffness (HP:0001387) | 2.22760232 |
| 75 | Scapular winging (HP:0003691) | 2.21921025 |
| 76 | Ventricular fibrillation (HP:0001663) | 2.20791628 |
| 77 | Abnormality of dentin (HP:0010299) | 2.19266913 |
| 78 | Biconcave vertebral bodies (HP:0004586) | 2.19074171 |
| 79 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.17893249 |
| 80 | Spinal rigidity (HP:0003306) | 2.16197944 |
| 81 | Conjunctival hamartoma (HP:0100780) | 2.15905917 |
| 82 | Insomnia (HP:0100785) | 2.14849416 |
| 83 | Ventricular arrhythmia (HP:0004308) | 2.14683518 |
| 84 | Multiple enchondromatosis (HP:0005701) | 2.13283638 |
| 85 | Bladder diverticulum (HP:0000015) | 2.11600268 |
| 86 | Dysostosis multiplex (HP:0000943) | 2.11066148 |
| 87 | Broad face (HP:0000283) | 2.10588319 |
| 88 | Dilated cardiomyopathy (HP:0001644) | 2.09736455 |
| 89 | Premature rupture of membranes (HP:0001788) | 2.09679086 |
| 90 | Hamartoma of the eye (HP:0010568) | 2.08817414 |
| 91 | Cellulitis (HP:0100658) | 2.08205342 |
| 92 | Mitral regurgitation (HP:0001653) | 2.08057882 |
| 93 | Hypertensive crisis (HP:0100735) | 2.07402055 |
| 94 | Shallow orbits (HP:0000586) | 2.06919739 |
| 95 | Hyperacusis (HP:0010780) | 2.05260875 |
| 96 | Nasal polyposis (HP:0100582) | 2.04817480 |
| 97 | Dilatation of the ascending aorta (HP:0005111) | 2.03955737 |
| 98 | Lymphangioma (HP:0100764) | 2.03089345 |
| 99 | Abnormality of the lower motor neuron (HP:0002366) | 2.02939168 |
| 100 | Genu recurvatum (HP:0002816) | 2.02257951 |
| 101 | Spondylolisthesis (HP:0003302) | 2.01840205 |
| 102 | Blue sclerae (HP:0000592) | 2.01666641 |
| 103 | Deformed tarsal bones (HP:0008119) | 2.01336956 |
| 104 | Upper motor neuron abnormality (HP:0002127) | 1.99031670 |
| 105 | Neck muscle weakness (HP:0000467) | 1.98810296 |
| 106 | Abnormality of macrophages (HP:0004311) | 1.98762728 |
| 107 | Palpitations (HP:0001962) | 1.98546691 |
| 108 | Hand muscle atrophy (HP:0009130) | 1.98479091 |
| 109 | Ketoacidosis (HP:0001993) | 1.98475066 |
| 110 | Distal lower limb amyotrophy (HP:0008944) | 1.98323160 |
| 111 | Aortic dissection (HP:0002647) | 1.96304139 |
| 112 | J-shaped sella turcica (HP:0002680) | 1.96266062 |
| 113 | Long toe (HP:0010511) | 1.95952255 |
| 114 | Generalized muscle weakness (HP:0003324) | 1.94819567 |
| 115 | Hypercortisolism (HP:0001578) | 1.94738714 |
| 116 | Ankle contracture (HP:0006466) | 1.94696079 |
| 117 | Aneurysm (HP:0002617) | 1.94116755 |
| 118 | Interstitial pulmonary disease (HP:0006530) | 1.93925838 |
| 119 | Testicular atrophy (HP:0000029) | 1.93359247 |
| 120 | Increased density of long bones (HP:0006392) | 1.93080334 |
| 121 | Rectal prolapse (HP:0002035) | 1.90984467 |
| 122 | Dysmetric saccades (HP:0000641) | 1.89486965 |
| 123 | Natal tooth (HP:0000695) | 1.88859101 |
| 124 | Nail dystrophy (HP:0008404) | 1.87022087 |
| 125 | Facial diplegia (HP:0001349) | 1.86867438 |
| 126 | Rapidly progressive (HP:0003678) | 1.84967645 |
| 127 | Progressive muscle weakness (HP:0003323) | 1.84900499 |
| 128 | Limb-girdle muscle weakness (HP:0003325) | 1.84821935 |
| 129 | Polycythemia (HP:0001901) | 1.83135641 |
| 130 | Generalized amyotrophy (HP:0003700) | 1.81336415 |
| 131 | Hepatosplenomegaly (HP:0001433) | 1.81156479 |
| 132 | Adenoma sebaceum (HP:0009720) | 1.80219249 |
| 133 | Angiofibromas (HP:0010615) | 1.80219249 |
| 134 | Nuclear cataract (HP:0100018) | 1.79733345 |
| 135 | Vascular tortuosity (HP:0004948) | 1.79659639 |
| 136 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79311652 |
| 137 | Increased serum ferritin (HP:0003281) | 1.78854523 |
| 138 | Neurofibrillary tangles (HP:0002185) | 1.77815026 |
| 139 | Chronic obstructive pulmonary disease (HP:0006510) | 1.76596213 |
| 140 | Obstructive lung disease (HP:0006536) | 1.76596213 |
| 141 | Proximal amyotrophy (HP:0007126) | 1.75355426 |
| 142 | Mitral valve prolapse (HP:0001634) | 1.74752635 |
| 143 | Ketosis (HP:0001946) | 1.74275818 |
| 144 | Abnormality of the calcaneus (HP:0008364) | 1.74168926 |
| 145 | Stridor (HP:0010307) | 1.73331757 |
| 146 | Supranuclear gaze palsy (HP:0000605) | 1.71515689 |
| 147 | Cerebral inclusion bodies (HP:0100314) | 1.70890172 |
| 148 | Petechiae (HP:0000967) | 1.70590204 |
| 149 | Abnormality of the umbilical cord (HP:0010881) | 1.69897293 |
| 150 | Ulnar bowing (HP:0003031) | 1.69386331 |
| 151 | Abnormal gallbladder physiology (HP:0012438) | 1.69238451 |
| 152 | Cholecystitis (HP:0001082) | 1.69238451 |
| 153 | Aortic aneurysm (HP:0004942) | 1.69024770 |
| 154 | Hyperparathyroidism (HP:0000843) | 1.68878028 |
| 155 | Abnormal trabecular bone morphology (HP:0100671) | 1.68491629 |
| 156 | Gout (HP:0001997) | 1.68392574 |
| 157 | Prolonged QT interval (HP:0001657) | 1.67746409 |
| 158 | Long palpebral fissure (HP:0000637) | 1.67638287 |
| 159 | Upper limb muscle weakness (HP:0003484) | 1.67571563 |
| 160 | Slender build (HP:0001533) | 1.66401164 |
| 161 | Mesangial abnormality (HP:0001966) | 1.66119628 |
| 162 | Disproportionate tall stature (HP:0001519) | 1.65925521 |
| 163 | Prolonged neonatal jaundice (HP:0006579) | 1.65739517 |
| 164 | Lower limb amyotrophy (HP:0007210) | 1.65365740 |
| 165 | Glucose intolerance (HP:0000833) | 1.65187297 |
| 166 | Acanthosis nigricans (HP:0000956) | 1.64978836 |
| 167 | Hypertriglyceridemia (HP:0002155) | 1.62190928 |
| 168 | Short clavicles (HP:0000894) | 1.62099921 |
| 169 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.62051237 |
| 170 | Bowing of the arm (HP:0006488) | 1.61844997 |
| 171 | Bowed forearm bones (HP:0003956) | 1.61844997 |
| 172 | Onycholysis (HP:0001806) | 1.61590112 |
| 173 | Selective tooth agenesis (HP:0001592) | 1.57341052 |
| 174 | Coxa vara (HP:0002812) | 1.55506993 |
| 175 | Hypoventilation (HP:0002791) | 1.55091116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.88132454 |
| 2 | NME2 | 4.03667088 |
| 3 | TTN | 4.02688393 |
| 4 | PKN2 | 3.92820862 |
| 5 | TESK2 | 3.74506446 |
| 6 | IRAK3 | 3.32667067 |
| 7 | EEF2K | 2.88269780 |
| 8 | EPHA2 | 2.57439561 |
| 9 | PRKD3 | 2.57019786 |
| 10 | ERN1 | 2.49555660 |
| 11 | PDK4 | 2.37902078 |
| 12 | PDK3 | 2.37902078 |
| 13 | LIMK1 | 2.35315177 |
| 14 | PHKG1 | 2.28175418 |
| 15 | PHKG2 | 2.28175418 |
| 16 | TAOK2 | 2.22390222 |
| 17 | PIM2 | 2.15898006 |
| 18 | PRPF4B | 2.14424753 |
| 19 | ICK | 2.06290008 |
| 20 | MAP3K10 | 2.06273330 |
| 21 | ARAF | 1.98229645 |
| 22 | RIPK1 | 1.84176753 |
| 23 | PDGFRA | 1.83393077 |
| 24 | NEK1 | 1.80611004 |
| 25 | SMG1 | 1.80526095 |
| 26 | LMTK2 | 1.73395092 |
| 27 | VRK2 | 1.72403681 |
| 28 | DMPK | 1.71148660 |
| 29 | KDR | 1.68095930 |
| 30 | OBSCN | 1.52540659 |
| 31 | TESK1 | 1.51658070 |
| 32 | LRRK2 | 1.50528993 |
| 33 | PTK6 | 1.47939897 |
| 34 | BCKDK | 1.47082772 |
| 35 | ILK | 1.42993264 |
| 36 | PINK1 | 1.41271548 |
| 37 | BMX | 1.37986330 |
| 38 | TAOK1 | 1.31461312 |
| 39 | MST1R | 1.28769158 |
| 40 | SIK1 | 1.28286554 |
| 41 | MAP2K3 | 1.26782824 |
| 42 | KSR2 | 1.21506684 |
| 43 | DDR2 | 1.20267632 |
| 44 | TYRO3 | 1.19479420 |
| 45 | NTRK1 | 1.16304625 |
| 46 | MAP3K7 | 1.15666246 |
| 47 | MAPKAPK3 | 1.15213211 |
| 48 | ABL2 | 1.13589702 |
| 49 | BUB1 | 1.10423807 |
| 50 | PDK2 | 1.08966357 |
| 51 | MAP3K11 | 1.06419957 |
| 52 | LATS2 | 1.01894951 |
| 53 | PAK4 | 1.00049587 |
| 54 | CAMKK1 | 0.98152079 |
| 55 | STK38 | 0.92432440 |
| 56 | ALK | 0.87155032 |
| 57 | DAPK3 | 0.86281070 |
| 58 | BRAF | 0.85733526 |
| 59 | MAP3K14 | 0.83509323 |
| 60 | STK10 | 0.82596879 |
| 61 | MAP3K8 | 0.82021652 |
| 62 | ERBB4 | 0.81369381 |
| 63 | MYLK | 0.80605915 |
| 64 | PTK2B | 0.80430046 |
| 65 | PRKCH | 0.80146342 |
| 66 | CDK8 | 0.79195928 |
| 67 | MAP3K13 | 0.78098312 |
| 68 | PAK6 | 0.75993370 |
| 69 | DYRK1B | 0.75793691 |
| 70 | IRAK4 | 0.75019190 |
| 71 | PRKD2 | 0.74769487 |
| 72 | PAK1 | 0.74581747 |
| 73 | JAK3 | 0.73562937 |
| 74 | PRKD1 | 0.72491726 |
| 75 | RET | 0.69912255 |
| 76 | AURKA | 0.67553637 |
| 77 | MET | 0.65407263 |
| 78 | PAK2 | 0.64090899 |
| 79 | MTOR | 0.64021005 |
| 80 | DAPK1 | 0.63625696 |
| 81 | GRK7 | 0.62755666 |
| 82 | EPHB1 | 0.62691587 |
| 83 | FLT3 | 0.62444905 |
| 84 | MAP3K1 | 0.62307932 |
| 85 | NME1 | 0.59239621 |
| 86 | SCYL2 | 0.57386940 |
| 87 | MAPK12 | 0.57141589 |
| 88 | MAP4K1 | 0.56411137 |
| 89 | TGFBR2 | 0.55935269 |
| 90 | PDPK1 | 0.55742397 |
| 91 | PTK2 | 0.55356692 |
| 92 | PDK1 | 0.54825117 |
| 93 | MAP3K12 | 0.54565112 |
| 94 | PRKAA1 | 0.51271400 |
| 95 | EPHB2 | 0.51050650 |
| 96 | IKBKB | 0.50121514 |
| 97 | GRK6 | 0.49390860 |
| 98 | FGFR4 | 0.49311879 |
| 99 | TYK2 | 0.48923818 |
| 100 | ROCK2 | 0.48913810 |
| 101 | MAP2K6 | 0.47641359 |
| 102 | MAP3K9 | 0.45987781 |
| 103 | RPS6KA1 | 0.45753975 |
| 104 | MAPK11 | 0.45555023 |
| 105 | RPS6KA2 | 0.45497904 |
| 106 | IRAK2 | 0.45373411 |
| 107 | PRKG2 | 0.44695627 |
| 108 | RPS6KL1 | 0.43829647 |
| 109 | RPS6KC1 | 0.43829647 |
| 110 | RPS6KA4 | 0.43556758 |
| 111 | CDK11A | 0.43069947 |
| 112 | PDGFRB | 0.42511080 |
| 113 | CDK14 | 0.42191790 |
| 114 | SIK3 | 0.41774752 |
| 115 | NEK2 | 0.41356154 |
| 116 | CAMK1D | 0.40620941 |
| 117 | SIK2 | 0.40378809 |
| 118 | ROCK1 | 0.40107703 |
| 119 | CAMK1G | 0.39962656 |
| 120 | RPS6KA6 | 0.39805292 |
| 121 | MAPKAPK2 | 0.39193192 |
| 122 | TRPM7 | 0.39031004 |
| 123 | IKBKE | 0.38697114 |
| 124 | PIK3CG | 0.38037523 |
| 125 | ZAP70 | 0.37403509 |
| 126 | MAP2K4 | 0.37146706 |
| 127 | CDK15 | 0.36729613 |
| 128 | CAMK2G | 0.36682906 |
| 129 | CDC42BPA | 0.36390713 |
| 130 | HIPK2 | 0.36357600 |
| 131 | DAPK2 | 0.36318305 |
| 132 | PAK3 | 0.35065222 |
| 133 | MAP2K1 | 0.34774034 |
| 134 | AKT2 | 0.34695138 |
| 135 | EIF2AK1 | 0.34429762 |
| 136 | CDK7 | 0.34214688 |
| 137 | TBK1 | 0.34054292 |
| 138 | JAK2 | 0.33918142 |
| 139 | WNK4 | 0.33223919 |
| 140 | KIT | 0.32829355 |
| 141 | MAP3K3 | 0.32586160 |
| 142 | CSF1R | 0.32579862 |
| 143 | MOS | 0.31092781 |
| 144 | CAMK4 | 0.31011349 |
| 145 | CSK | 0.30447189 |
| 146 | STK24 | 0.30079480 |
| 147 | MAP2K2 | 0.29925001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.92174725 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.40826568 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.84706051 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.76500067 |
| 5 | Shigellosis_Homo sapiens_hsa05131 | 2.29504817 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.24293189 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.19261040 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.09568037 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.05908204 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.93271716 |
| 11 | Salmonella infection_Homo sapiens_hsa05132 | 1.92841377 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92655191 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89340671 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.80028076 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.71358876 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.69744123 |
| 17 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.68437560 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.62470565 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.60444204 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.60145676 |
| 21 | Prion diseases_Homo sapiens_hsa05020 | 1.59897618 |
| 22 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.53509041 |
| 23 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.52060504 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.51642240 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.47821811 |
| 26 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.47656825 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.46597102 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46521646 |
| 29 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.46216649 |
| 30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.44718480 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.44667481 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42744993 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.42579832 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.42422681 |
| 35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.41918162 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40662815 |
| 37 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.37234285 |
| 38 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.35433064 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.34221287 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33698355 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32609598 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 1.32311896 |
| 43 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.32085545 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31919833 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.27928607 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.27799856 |
| 47 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.25607413 |
| 48 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.25593008 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24355300 |
| 50 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.23692218 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22600195 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.22172282 |
| 53 | Ribosome_Homo sapiens_hsa03010 | 1.22050443 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 1.21532735 |
| 55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20791803 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20561760 |
| 57 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.15975034 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13913288 |
| 59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.13512160 |
| 60 | Malaria_Homo sapiens_hsa05144 | 1.13392950 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.12301205 |
| 62 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10885551 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09638829 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08630064 |
| 65 | DNA replication_Homo sapiens_hsa03030 | 1.08095780 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06055291 |
| 67 | Base excision repair_Homo sapiens_hsa03410 | 1.05443348 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04537612 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99545871 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.99436195 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.99238546 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.97228214 |
| 73 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97225794 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.97037490 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96991699 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96419393 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.95296148 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94715923 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.92732554 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.92465718 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92420467 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90855699 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.90508594 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90504970 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90459844 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.90416706 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.89579549 |
| 88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89000094 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88581255 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88020541 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85890717 |
| 92 | Tuberculosis_Homo sapiens_hsa05152 | 0.85696848 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85176005 |
| 94 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84981757 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.83436501 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.83147600 |
| 97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82517816 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.81281781 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80193566 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77061204 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76999487 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76867840 |
| 103 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75815718 |
| 104 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.75179017 |
| 105 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74156885 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74132883 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.73827721 |
| 108 | Legionellosis_Homo sapiens_hsa05134 | 0.72292132 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.72148128 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71155759 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.71084299 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70447970 |
| 113 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68720928 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68555099 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67231767 |
| 116 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66467813 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66268809 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66084983 |
| 119 | Tight junction_Homo sapiens_hsa04530 | 0.65936243 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64916051 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64733381 |
| 122 | Allograft rejection_Homo sapiens_hsa05330 | 0.64079486 |
| 123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63689134 |
| 124 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62305648 |
| 125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62188367 |
| 126 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61976258 |
| 127 | Platelet activation_Homo sapiens_hsa04611 | 0.61368128 |
| 128 | Adherens junction_Homo sapiens_hsa04520 | 0.61161595 |
| 129 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59877021 |
| 130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59393405 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59223713 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57329020 |
| 133 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56849253 |
| 134 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56800672 |
| 135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56426663 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56371170 |
| 137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55810672 |
| 138 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.55744761 |
| 139 | Spliceosome_Homo sapiens_hsa03040 | 0.52299517 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.51642188 |
| 141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51399299 |
| 142 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51390196 |
| 143 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.49201947 |
| 144 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48444190 |
| 145 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47680584 |
| 146 | Renin secretion_Homo sapiens_hsa04924 | 0.47556358 |
| 147 | Gap junction_Homo sapiens_hsa04540 | 0.46803866 |
| 148 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46796759 |
| 149 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46451856 |
| 150 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46055749 |
| 151 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45810390 |
| 152 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44317430 |
| 153 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44063133 |
| 154 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43996587 |
| 155 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43410978 |
| 156 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42299488 |
| 157 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38852278 |
| 158 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37712959 |
| 159 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37368019 |
| 160 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.36563943 |
| 161 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36025177 |

